We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Global Regulatory News (JARA)

Share Price Information for Jpmorgan Global (JARA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.20
Ask: 69.60
Change: -2.10 (-2.95%)
Spread: 1.40 (2.053%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 71.10
JARA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration and Update

23 Apr 2020 15:02

RNS Number : 6975K
JPMorgan Global Core Real Assets Ld
23 April 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CORE REAL ASSETS LIMITED

(the "Company" or "JARA")

 

DIVIDEND DECLARATION AND UPDATE

 

 

Legal Entity Identifier: 549300D8JHZTH6GI8F97

Information disclosed in accordance with DTR 6.1.13

 

Second Quarterly Interim Dividend

 

The Directors have declared a second quarterly interim dividend of 0.75p per share, to be paid on 28th May 2020 to shareholders on the register as at the close of business on 1st May 2020. The ex-dividend date will be 30th April 2020. The Company's first quarterly dividend of 0.75 pence per share was paid on 27th February 2020.

 

· As detailed in the Prospectus, the Company is targeting a dividend yield on the Ordinary Shares of 2% to 3%. (on the basis of the Initial Issue Price), in the first 12 months from the date of Initial Admission. Post this second dividend, the Company will have paid 1.5p per share since its 24th September 2019 IPO and remains on track to meet its dividend target.

· The Company has so far invested approximately 40% of the proceeds arising from its IPO and from subsequent share issuance. The current turmoil in financial markets has meant capital has been drawn down slower than originally intended, but we remain on course be in fully invested at or around 12 months from IPO as stated in the Prospectus. Importantly, this does not impact the Company's long term return assumptions and may in fact provide a benefit.

· In the short term, due to the fall in money market rates, the interest income which the Company is receiving on its near cash instruments has declined as rate cuts in response to the coronavirus pandemic have reduced the yields available on these instruments.

· While, in the short term, this means the Company's liquidity is higher than planned, the Manager views this as a net positive as it provides the opportunity to deploy cash into investments at lower prices, and therefore higher yields, providing longer term support to the dividend.

 

These effects mean there is a short term reduction in the income account and, until further capital is drawn into the underlying strategies, the Directors intend to maintain the current level of dividend payments, supplementing the Company's earnings by using the reserves accumulated in the share premium account which, following payment of the second interim dividend, will stand at approximately 1.62 pence per share. The Directors therefore see no immediate threat to the level of quarterly dividends being paid, but they recognise that, in the longer term, their ability to maintain and grow the dividend will depend on the rate at which the fund can invest and in the continuing success of the underlying strategies.

 

In summary, despite current market conditions, with the proposed drawdown profile of the underlying strategies, the Company remains on track to hit full deployment at or around the 12 month point, as outlined in the Prospectus. Importantly, given the growth of JARA and reduction in fees and ongoing costs, we remain comfortably able to achieve the long term target of 4% - 6% income on issue price for the second 12 month period and current market conditions could allow a potentially attractive entry point for the Company's capital to help support the long term total returns of 7% - 9%.

 

In due course, an update will be provided to investors on the progress of the Company's investment portfolio.

 

 

23rd April 2020

 

 

For further information:

 

Alison Vincent

JPMorgan Funds Limited

Company Secretary

 

020 7742 4000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVUOVORRKUSUAR
Date   Source Headline
12th Apr 20245:10 pmRNSQuotedData's Weekly News & Interview
8th Apr 20247:00 amRNSMonthly Portfolio Update
3rd Apr 20246:25 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:04 pmRNSBlock listing Interim Review
2nd Apr 20245:00 pmRNSClosed Period Announcement
25th Mar 20244:33 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSQuarterly Net Asset Value and Portfolio Update
15th Mar 20245:46 pmRNSDirector/PDMR Shareholding
1st Mar 20249:53 amRNSTotal Voting Rights
19th Feb 20244:54 pmRNSTransaction in Own Shares
16th Feb 20244:53 pmRNSTransaction in Own Shares
15th Feb 20245:09 pmRNSTransaction in Own Shares
13th Feb 20245:09 pmRNSTransaction in Own Shares
7th Feb 20245:00 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSMonthly Portfolio Update
6th Feb 20244:51 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20244:57 pmRNSTransaction in Own Shares
2nd Feb 20244:47 pmRNSTransaction in Own Shares
29th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
18th Jan 20247:00 amRNSDividend Declaration
5th Jan 20247:00 amRNSMONTHLY PORTFOLIO UPDATE
2nd Jan 202411:39 amRNSTotal Voting Rights
21st Dec 20237:00 amRNSNet Asset Value(s)
19th Dec 20234:23 pmRNSTransaction in Own Shares
1st Dec 202312:17 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSLive Webinar hosted by Capital Access Group
10th Nov 20237:00 amRNSMonthly Net Asset Value
8th Nov 20235:00 pmRNSTransaction in Own Shares
7th Nov 20235:01 pmRNSTransaction in Own Shares
3rd Nov 20235:11 pmRNSTransaction in Own Shares
2nd Nov 20235:18 pmRNSTransaction in Own Shares
1st Nov 20235:20 pmRNSTransaction in Own Shares
1st Nov 202311:13 amRNSTotal Voting Rights
31st Oct 20235:07 pmRNSTransaction in Own Shares
30th Oct 20234:13 pmRNSTransaction in Own Shares
27th Oct 20235:12 pmRNSTransaction in Own Shares
26th Oct 20235:14 pmRNSTransaction in Own Shares
24th Oct 20235:18 pmRNSTransaction in Own Shares
18th Oct 20237:00 amRNSDividend Declaration
13th Oct 20234:48 pmRNSTransaction in Own Shares
12th Oct 20235:07 pmRNSTransaction in Own Shares
10th Oct 20235:01 pmRNSTransaction in Own Shares
9th Oct 20235:03 pmRNSTransaction in Own Shares
6th Oct 20235:16 pmRNSTransaction in Own Shares
4th Oct 20237:00 amRNSMonthly Net Asset Value
3rd Oct 20235:19 pmRNSTransaction in Own Shares
2nd Oct 202311:35 amRNSTotal Voting Rights
28th Sep 20234:58 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.